July 15, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

July 15, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

July 14, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

July 01, 2026

Medical Oddities: Do Jellyfish Hold a Healing Secret?

Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

MDSpire News

June 29, 2026

Fertility Preservation Access Remains ‘Limited and Unequal’ for Many Girls and Young Women With Cancer

A review of existing literature from 2006 to 2025 revealed inconsistent implementation of fertility preservation guidelines, resulting in inequities across gender, race, geography, and socioeconomic s...

The ASCO Post

June 29, 2026

Fertility Preservation Access Remains ‘Limited and Unequal’ for Many Girls and Young Women With Cancer

A review of existing literature from 2006 to 2025 revealed inconsistent implementation of fertility preservation guidelines, resulting in inequities across gender, race, geography, and socioeconomic s...

The ASCO Post

June 26, 2026

Surveillance May Reduce CIN 2 Overtreatment

Risk-based management may reduce unnecessary excisions in selected patients with CIN 2.

MDSpire News

June 25, 2026

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

MDSpire News

June 24, 2026

New Section Chief of Medical Oncology and Hematology and Deputy Director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital Named

An international leader in breast cancer care and clinical investigation, he is widely recognized for his collaborative leadership approach and focus on quality, safety, and innovation in cancer care.

The ASCO Post

June 24, 2026

New Section Chief of Medical Oncology and Hematology and Deputy Director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital Named

An international leader in breast cancer care and clinical investigation, he is widely recognized for his collaborative leadership approach and focus on quality, safety, and innovation in cancer care.

The ASCO Post